Position in ETON
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$6,181,041
-$2,259,148 QoQ
Shares Held
170,747
-50.1% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
4.56%
of 13F equity value
Holder Rank
#25
of 163 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CANNELL CAPITAL LLC holds $6,302,599 across 2 Drug Manufacturers - Specialty & Generic names. ETON ranks #1 (98.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ETON |
Eton Pharmaceuticals, Inc.
This page
|
170,747 | $6,181,041 | |
| 2 | CRON |
Cronos Group Inc.
|
43,726 | $121,558 |
All Filings in ETON
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,181,041 | 170,747 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $8,440,189 | 341,985 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,668,066 | 216,917 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,895,950 | 455,405 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,531,493 | 388,175 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $8,973,943 | 691,367 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,079,222 | 381,323 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||